Broadly suppressing effects of histone acetylation by targeting the epigenetic reader BRD4 with the small-molecule inhibitor JQ1 repressed angiogenesis-related gene expression and inhibited ex vivo tumor formation (Tanaka et al., 2023). The gene discussed is BRD4; the disease is neoplasm.